In the final part of his Pharma Commerce video interview, Franco Stevanato, CEO of Stevanato Group, explains that with plant ...
Bayer AG’s pharmaceuticals unit is on track for a return to growth as new drugs for cancer and kidney disease offset sales ...
In a recent interview, OptimizeRx Chief Commercial Officer Theresa Greco discussed the company’s evolving strategy in the dynamic digital health space. She highlighted the firm’s focus on expanding ...
Entertainment Holding Corp. (Nasdaq:AENT) and Processa Pharmaceuticals, Inc. (Nasdaq:PCSA) on the RedChip Small Stocks, Big ...
Saharsh Davuluri, Neuland Labs, covers M&A blending, geopolitical shifts, and supply chain de-risking in this look back at ...
New Hampshire Republican Senate candidate John E. Sununu tried to hide his ties to big pharma in a recent interview on the ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...